Diabetes Type 2

Once-weekly Semaglutide 2.0 mg Bests 1.0 mg Dose for A1c, Weight Reduction
November 18, 2020

Once-weekly semaglutide 2.0 mg vs 1.0 mg led to statistically significant, superior reductions in A1c and weight in type 2 diabetes patients not at goal, study finds.

DAPA-CKD Trial Findings Could Transform CKD Therapy
November 12, 2020

AHA: DAPD-CKD investigator Prof John McMurray talks to Patient Care about the “revolutionary” findings he will highlight at the AHA sessions on opening day.

Higher Green Tea and Coffee Intake May Reduce Mortality Risk in Patients with T2D
November 09, 2020

A new study of Japanese adults with type 2 diabetes found dual consumption of green tea and coffee reduced mortality risk by >60%.

November 04, 2020

Preventive Cardiology Collection Table of Contents: Expert video interviews, short, clinical guideline-focused quizzes, facts at-a-glance slideshows, plus news.

Guideline-directed Weight Loss: 4 Questions for Primary Care Physicians
October 29, 2020

Rapidly rising obesity rates in the US threaten to reverse decades of effort against cardiometabolic disease. How well do you know what experts recommend for your at-risk patients?

The Obesity Paradox: How Real is It?
October 29, 2020

Carl "Chip" Lavie, MD, author of the original book titled, "The Obesity Paradox" explains the paradox of metabolic health in the obese, how it wanes, and an essential element to maintain it.

4 Questions for PCPs on Prevention and Management of Cardiometabolic Diseases
October 28, 2020

Waist circumference measures, complementary antihypertensives, appropriate exercise levels for T2D patients--test what you know about cardiometabolic risk and management.

Finerenone Slows Renal Decline, Improves CV Outcomes in FIDELIO-DKD
October 23, 2020

The investigational mineralocorticoid receptor antagonist slowed progression to renal failure by 18% and reduced the composite cardiovascular outcome by 14%, authors report.

DPP-4 Inhibitor Found to Boost Survival in T2D Patients with COVID-19
October 06, 2020

According to a new study, adults with T2D who were hospitalized with COVID-19 in northern Italy had a lower mortality rate when treated with sitagliptin.

Patients with T2D at Greater Risk for Vascular than Other Dementias
September 24, 2020

The association of vascular dementia with T2D is stronger than that of nonvascular or Alzheimer dementia, according to a study presented at EASD.